Stepan Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Los beneficios de Stepan han disminuido a una tasa media anual de -2.2%, mientras que en la industria Chemicals los beneficios crecieron en un 13.9% anualmente. Los ingresos han ido creciendo a una tasa media de 8.3% al año. La rentabilidad financiera de Stepan es de 3.3%, y sus márgenes netos son de 1.7%.

Información clave

-6.1%

Tasa de crecimiento de los beneficios

-5.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	12.9%
Tasa de crecimiento de los ingresos	7.7%
Rentabilidad financiera	3.1%
Margen neto	1.7%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Stepan Company: Don't Try To Catch The Falling Knife, Still Potentially Overvalued

Sep 17

Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Aug 31

Stepan's Shares Are Reaching Even More Appealing Prices

Aug 28

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Jul 18

Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

Jul 06

Stepan Company: A Downward Revision Is Warranted

Jun 09

Is Stepan (NYSE:SCL) Using Too Much Debt?

May 23

At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

May 01

Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth

Mar 25

Returns On Capital At Stepan (NYSE:SCL) Have Stalled

Mar 08

Stepan Q4 2022 Earnings Preview

Feb 15

Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly

Feb 02

Stepan Company (NYSE:SCL) Shares Could Be 30% Below Their Intrinsic Value Estimate

Jan 05

Stepan Company: Expect Outperformance To Continue

Jan 03

Stepan (NYSE:SCL) Has Some Way To Go To Become A Multi-Bagger

Dec 03

Stepan (NYSE:SCL) Is Paying Out A Larger Dividend Than Last Year

Nov 17

Stepan Company: Consistent Dividend Growth In Times Of Uncertainty

Oct 13

Stepan Company's (NYSE:SCL) Intrinsic Value Is Potentially 90% Above Its Share Price

Sep 20

Stepan (NYSE:SCL) Has A Pretty Healthy Balance Sheet

Aug 23

Stepan Company: A Growing Dividend Stream Worth The Price

Aug 14

Stepan declares $0.335 dividend

Jul 27

Stepan (NYSE:SCL) Has Some Way To Go To Become A Multi-Bagger

Jul 25

Stepan Company (NYSE:SCL) Shares Could Be 35% Below Their Intrinsic Value Estimate

Jun 10

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Stepan. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:SCL Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	2,226	38	144	58
31 Dec 23	2,326	40	146	59
30 Sep 23	2,421	52	142	60
30 Jun 23	2,578	79	157	63
31 Mar 23	2,749	118	159	65
31 Dec 22	2,773	147	151	67
30 Sep 22	2,756	153	155	67
30 Jun 22	2,640	151	144	66
31 Mar 22	2,484	142	148	64
31 Dec 21	2,346	138	159	63
30 Sep 21	2,231	151	163	62
30 Jun 21	2,092	147	168	61
31 Mar 21	1,958	140	168	59
31 Dec 20	1,870	127	154	58
30 Sep 20	1,820	118	146	56
30 Jun 20	1,807	111	142	56
31 Mar 20	1,820	106	139	55
31 Dec 19	1,859	103	155	55
30 Sep 19	1,880	105	141	53
30 Jun 19	1,937	101	146	54
31 Mar 19	1,984	104	139	54
31 Dec 18	1,994	111	134	54
30 Sep 18	2,001	97	143	55
30 Jun 18	1,981	97	134	53
31 Mar 18	1,956	92	140	54
31 Dec 17	1,925	101	136	54
30 Sep 17	1,872	90	139	54
30 Jun 17	1,829	90	147	56
31 Mar 17	1,789	90	146	56
31 Dec 16	1,766	86	150	56
30 Sep 16	1,765	91	151	56
30 Jun 16	1,764	94	137	54
31 Mar 16	1,762	83	141	52
31 Dec 15	1,776	76	138	50
30 Sep 15	1,811	69	123	47
30 Jun 15	1,859	58	129	46
31 Mar 15	1,910	65	113	45
31 Dec 14	1,927	57	109	45
30 Sep 14	1,947	62	117	47
30 Jun 14	1,931	68	116	48
31 Mar 14	1,902	67	120	47
31 Dec 13	1,881	73	124	47
30 Sep 13	1,834	78	123	48
30 Jun 13	1,799	77	118	47

Ingresos de calidad: SCL tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(1.7%) de SCL son inferiores a los del año pasado (5.3%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de SCL han disminuido en un 2.2% al año en los últimos 5 años.

Acelerando crecimiento: SCL ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: SCL tuvo un crecimiento negativo de los beneficios (-72.7%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-11.9%).

Stepan Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Stepan Company to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings: EPS misses analyst expectations

Stepan Company to Report Q4, 2023 Results on Feb 20, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Stepan Company to Report Q3, 2023 Results on Oct 18, 2023

Recent updates

First quarter dividend of US$0.38 announced

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Stepan Company Declares Quarterly Cash Dividend, Payable on June 14, 2024

Stepan Company to Report Q1, 2024 Results on Apr 30, 2024

Stepan Company's (NYSE:SCL) Price In Tune With Earnings

Stepan Company, Annual General Meeting, Apr 30, 2024

Is There Now An Opportunity In Stepan Company (NYSE:SCL)?

Non-Executive Chairman recently sold US$261k worth of stock

Consensus EPS estimates fall by 33%

Non-Executive Chairman notifies of intention to sell stock

Fourth quarter dividend of US$0.38 announced

Full year 2023 earnings: EPS misses analyst expectations

Stepan Declares Quarterly Cash Dividend, Payable on March 15, 2024

Is Stepan (NYSE:SCL) Using Too Much Debt?

Stepan Company: It's Wise To Remain Cautious

Stepan Company Appoints Susan M. Lewis as Director

Non-Executive Chairman exercised options and sold US$694k worth of stock

Insufficient new directors

Stepan Company to Report Q4, 2023 Results on Feb 20, 2024

With Stepan Company (NYSE:SCL) It Looks Like You'll Get What You Pay For

Capital Allocation Trends At Stepan (NYSE:SCL) Aren't Ideal

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 27%?

Stepan Company: An Unfortunate Development Resulting In An Upside

Upcoming dividend of US$0.38 per share at 1.9% yield

Consensus EPS estimates fall by 15%

New minor risk - Financial position

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Stepan Company Declares Quarterly Cash Dividend, Payable on December15, 2023

Price target decreased by 23% to US$95.00

When Should You Buy Stepan Company (NYSE:SCL)?

Stepan Company to Report Q3, 2023 Results on Oct 18, 2023

Stepan Company: Don't Try To Catch The Falling Knife, Still Potentially Overvalued

Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Stepan's Shares Are Reaching Even More Appealing Prices

Upcoming dividend of US$0.36 per share at 1.7% yield

Non-Executive Chairman notifies of intention to sell stock

Consensus EPS estimates fall by 34%

Stepan Company Declares Quarterly Cash Dividend, Payable on September 15, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Consensus EPS estimates fall by 15%

Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

New minor risk - Dividend sustainability

Stepan Company to Report Q2, 2023 Results on Jul 26, 2023

Stepan Company Announces Retirement of Arthur W. Mergner, Executive Vice President, Effective July 3, 2023

Stepan Company: A Downward Revision Is Warranted

Executive Vice President exercised options and sold US$340k worth of stock

Is Stepan (NYSE:SCL) Using Too Much Debt?

Upcoming dividend of US$0.36 per share at 1.6% yield

Lead Independent Director notifies of intention to sell stock

CEO, President & Director recently sold US$180k worth of stock

CEO, President & Director notifies of intention to sell stock

At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

First quarter 2023 earnings: EPS misses analyst expectations

Price target decreased by 8.5% to US$129

Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth

Insider recently sold US$50k worth of stock

Returns On Capital At Stepan (NYSE:SCL) Have Stalled

Now 22% undervalued after recent price drop

Non-Executive Chairman recently sold US$506k worth of stock

Non-Executive Chairman notifies of intention to sell stock

Upcoming dividend of US$0.36 per share at 1.4% yield

Full year 2022 earnings: EPS misses analyst expectations

Stepan Company Declares Quarterly Cash Dividend, Payable on March 15, 2023

Now 22% undervalued after recent price drop

Stepan Q4 2022 Earnings Preview

Non-Executive Chairman exercised options and sold US$730k worth of stock

Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly

Desglose de ingresos y gastos
Beta